I was privileged to attend the recent Government Accountability Board (GAB) meeting and was so proud and pleased to see that all six of these non-partisan board members seemed to me determined to put an end to sham issue ads.
In a nut shell this process refers to the misuse of so called “issue ads” by the super-rich and powerful to anonymously attack and defeat a political candidate through a barrage of insanely costly negative TV ads especially in the last few days before Election Day.
The Wisconsin Democracy Campaign estimates that nearly eight million dollars was spend on such spurious ads during the last two Supreme Court elections. It is clear to this citizen that the Board has both the authority and the means to bring an end these corrupt practices. After all, this watchdog group has the statutory authority to fight corruption and/or the appearance of corruption, and to ensure the integrity of our election process.
How many of us really believe that our constitutional fathers ever intended for us to equate our so-called “free speech” rights with exorbitant corporate spending rights while the people’s right to peacefully assemble and speak out at political events erodes more and more each day. We can be sure that the Wisconsin Lobbyist Association and mistaken free speech advocates will continue to fight for the right to spend, spend, and spend and thus squander away and make more impotent each day the legitimate and true voice of the people.
Let all Americans who love our sacred liberties, follow the lead of these six courageous clean government watchdog officials and more recently John Wiley and the Epic Corporation, and stand up with them to the corporate lobbyists and the Wisconsin Manufacturers and Commerce. Call the Board’s office at 608-266-8005 and commend them for their industry and fine work since beginning in January 08 and assure them that they have your support.
Respectfully, William R. Benedict
Tuesday, September 30, 2008
Tuesday, September 9, 2008
A public health care benefit for all Wisconsin citizens
Dialogue
Madison-area Urban Ministry
July-September 2008
By now we know that solving Wisconsin’s ever-growing home health care costs is a multifaceted problem and will not be solved by any single solution. And while there are many comprehensive solutions being proposed, none of them go directly to the core issue---monolithic and predatory health care pharmaceutical pricing practices.
In 2005 my partner and I were vacationing in San Diego California. While reading the San Diego Tribune I just happened to read about California’s 3 billion dollar stem cell research program and about the many health care stakeholder groups who all were fighting for something they were calling a “public benefit.”
I continued to read and soon learned what they meant by the words, “public benefit.” They wanted to make sure that medical breakthroughs and medicines developed through stem cell research, and funded by their tax dollars, would be available and affordable to every citizen in California.
When we weigh the billions and billions of dollars to be both made and saved through miracle cures of our worse most debilitating diseases and by such life enhancements as restored memory, increased mobility, regenerated body parts, and most of all, increased longevity, only then can we begin to appreciate the real scope and importance of the health care policy issue now before us.
Californians have learned their lessons well from our nation’s health care problems and have decided to go directly to the root of our health care pricing crisis. They are no longer going to pay twice for their health care: Once for the research and once again for the exorbitantly priced medications and therapies.
Wisconsin citizens should follow California’s lead and pass legislation now that supports federal and state funding of stem cell research in Wisconsin along with public health care benefit safeguards.
“Public health care benefit safeguards” can mean anything from requiring a successful grantee to return 25 percent of their profit back on their billion-dollar stem cell-based drug discovery to the state of Wisconsin to be put in a special patient health care fund.
Or a successful grantee would simply be required to submit a plan to ensure affordable prices for all Wisconsin citizens, especially the medium-and-low income and underserved populations.
The bottom line is that you and I as Wisconsin citizens can prove to ourselves and our grandchildren, and future generations, that we have learned our lesson from exorbitant health care pricing. We have learned not to give our money to people without first asking who they are, why they need it, and how they plan on using it. This new policy of asking the public-funded grantee to meet certain expectations and provide some return on our investment is better than writing a blank check and continuing with health care in Wisconsin as we now know it.
Now is the time for Wisconsin policy makers to decide whether the miracle cures promised will be made accessible and affordable to Wisconsin families with cell-based diseases.
The answer to this question must be reflected in the language of the state’s financial and tax research innovation incentives now being proposed.
Asking the grantees to do the right thing after giving away the farm is like asking the fox to cough up the chickens after giving him the key to the hen house.
Without grass roots action now by all Wisconsin citizens we should not expect that cell-based therapies and drugs derived from this research will eventually benefit all of us as health consumers and taxpayers.
Madison-area Urban Ministry
July-September 2008
By now we know that solving Wisconsin’s ever-growing home health care costs is a multifaceted problem and will not be solved by any single solution. And while there are many comprehensive solutions being proposed, none of them go directly to the core issue---monolithic and predatory health care pharmaceutical pricing practices.
In 2005 my partner and I were vacationing in San Diego California. While reading the San Diego Tribune I just happened to read about California’s 3 billion dollar stem cell research program and about the many health care stakeholder groups who all were fighting for something they were calling a “public benefit.”
I continued to read and soon learned what they meant by the words, “public benefit.” They wanted to make sure that medical breakthroughs and medicines developed through stem cell research, and funded by their tax dollars, would be available and affordable to every citizen in California.
When we weigh the billions and billions of dollars to be both made and saved through miracle cures of our worse most debilitating diseases and by such life enhancements as restored memory, increased mobility, regenerated body parts, and most of all, increased longevity, only then can we begin to appreciate the real scope and importance of the health care policy issue now before us.
Californians have learned their lessons well from our nation’s health care problems and have decided to go directly to the root of our health care pricing crisis. They are no longer going to pay twice for their health care: Once for the research and once again for the exorbitantly priced medications and therapies.
Wisconsin citizens should follow California’s lead and pass legislation now that supports federal and state funding of stem cell research in Wisconsin along with public health care benefit safeguards.
“Public health care benefit safeguards” can mean anything from requiring a successful grantee to return 25 percent of their profit back on their billion-dollar stem cell-based drug discovery to the state of Wisconsin to be put in a special patient health care fund.
Or a successful grantee would simply be required to submit a plan to ensure affordable prices for all Wisconsin citizens, especially the medium-and-low income and underserved populations.
The bottom line is that you and I as Wisconsin citizens can prove to ourselves and our grandchildren, and future generations, that we have learned our lesson from exorbitant health care pricing. We have learned not to give our money to people without first asking who they are, why they need it, and how they plan on using it. This new policy of asking the public-funded grantee to meet certain expectations and provide some return on our investment is better than writing a blank check and continuing with health care in Wisconsin as we now know it.
Now is the time for Wisconsin policy makers to decide whether the miracle cures promised will be made accessible and affordable to Wisconsin families with cell-based diseases.
The answer to this question must be reflected in the language of the state’s financial and tax research innovation incentives now being proposed.
Asking the grantees to do the right thing after giving away the farm is like asking the fox to cough up the chickens after giving him the key to the hen house.
Without grass roots action now by all Wisconsin citizens we should not expect that cell-based therapies and drugs derived from this research will eventually benefit all of us as health consumers and taxpayers.
Subscribe to:
Posts (Atom)